enGene Holdings Inc. (ENGN) Income Statement
ENGN FY2025 at a glance
Fiscal year ended October 31, 2025 · U.S. dollarsENGN revenue and net income
ENGN growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ENGN quarterly EPS vs estimates
enGene beat the analyst EPS estimate in 4 of the last 8 quarters.
ENGN income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $509,000 | $323,000 | $175,000 | — | — | — |
| Gross profit | −$509,000 | −$323,000 | −$175,000 | — | — | — |
| Research & development | $94.5M | $38.3M | $16.5M | $15.5M | $12.5M | $10.6M |
| Sales, general & admin | $28.7M | $24.0M | $8.5M | $3.3M | $3.2M | $3.2M |
| Total operating expenses | $123.2M | $62.3M | $26.1M | $19.4M | $15.9M | $13.9M |
| Operating income | −$123.2M | −$62.3M | −$26.1M | −$19.4M | −$15.9M | −$13.9M |
| Interest income | $9.4M | $10.4M | $1.1M | $129,000 | $25,000 | $56,000 |
| Interest expense | $3.0M | $2.8M | $5.0M | $1.4M | $5.0M | $3.7M |
| Income before taxes | −$117.3M | −$55.2M | −$99.9M | −$24.4M | −$23.4M | −$15.1M |
| Income taxes | — | −$19,000 | $17,000 | $22,000 | $4.9M | $4.3M |
| Net income | −$117.3M | −$55.1M | −$99.9M | −$24.5M | −$23.4M | −$15.1M |
| EBITDA | −$113.8M | −$52.0M | −$94.8M | −$22.8M | −$18.1M | −$12.9M |
| EPS (diluted) | −$2.29 | −$1.50 | −$4.65 | −$0.02 | −$1.48 | — |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 | Apr '24 | Jan '24 | Oct '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $480,000 | $0 | $0 | $0 | $0 |
| Cost of revenue | $178,000 | $180,000 | $189,000 | $171,000 | $130,000 | $106,000 | $102,000 | $240,000 | $82,000 | $78,000 | $80,000 | — |
| Gross profit | −$178,000 | −$180,000 | −$189,000 | −$171,000 | −$130,000 | −$106,000 | −$102,000 | $240,000 | −$82,000 | −$78,000 | −$80,000 | — |
| Research & development | $20.1M | $22.2M | $22.3M | $31.7M | $22.6M | $20.2M | $20.0M | $11.3M | $11.5M | $9.9M | $5.6M | $5.7M |
| Sales, general & admin | $13.9M | $9.8M | $8.9M | $10.0M | $6.7M | $6.0M | $6.6M | $7.7M | $5.2M | $6.1M | $3.6M | $4.4M |
| Total operating expenses | $34.0M | $32.0M | $31.0M | $39.5M | $29.9M | $27.1M | $26.6M | $17.5M | $16.8M | $17.3M | $10.8M | $10.4M |
| Operating income | $34.0M | $32.0M | −$31.2M | −$39.5M | −$29.9M | −$27.1M | −$26.6M | −$17.5M | −$16.8M | −$17.3M | −$10.8M | −$10.4M |
| Interest income | $2.4M | $2.7M | $2.7M | $2.0M | $2.2M | $2.5M | $2.7M | $3.0M | $3.4M | $3.0M | $1.0M | $1.0M |
| Interest expense | $843,000 | $745,000 | $732,000 | $750,000 | $758,000 | $734,000 | $752,000 | $756,000 | $751,000 | $728,000 | $563,000 | $1.2M |
| Income before taxes | $32.5M | $30.2M | −$29.8M | −$38.4M | −$28.8M | −$25.6M | −$24.6M | −$15.3M | −$14.2M | −$15.0M | −$10.7M | −$82.5M |
| Income taxes | — | — | — | −$497,000 | $239,000 | $240,000 | $18,000 | $19,000 | −$29,000 | $21,000 | −$30,000 | −$51.7M |
| Net income | $32.5M | $30.2M | −$29.8M | −$37.9M | −$29.0M | −$25.8M | −$24.6M | −$15.3M | −$14.1M | −$15.0M | −$10.7M | −$82.5M |
| EBITDA | −$33.8M | −$31.8M | −$28.8M | −$37.5M | −$27.9M | −$24.7M | −$23.7M | −$14.4M | −$13.3M | −$14.2M | −$10.1M | −$81.3M |
| EPS (diluted) | $0.47 | −$0.43 | −$0.44 | −$0.73 | −$0.57 | −$0.51 | −$0.48 | −$0.34 | −$0.32 | −$0.38 | −$0.46 | −$4.51 |
| Gross margin | — | — | — | — | — | — | — | 50.0% | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | −3,636.5% | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | −3,187.3% | — | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ENGN's financial statements (latest annual report filed December 22, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ENGN financial results
enGene reported no revenue in fiscal year 2025 (ended October 31, 2025). It had a net loss of $117.3 million. Diluted earnings per share came to −$2.29.
See the ENGN stock overview for the latest quote and news, or the ENGN chart for price history and technical indicators.
ENGN income statement FAQ
Does enGene have revenue?
enGene reported no revenue for fiscal year 2025, which ended on October 31, 2025.
Is enGene profitable?
No. enGene reported a net loss of $117.3 million in fiscal 2025.
How much does enGene spend on research and development?
enGene spent $94.5 million on research and development in fiscal 2025.
What are enGene's earnings per share?
enGene earned $-2.29 per diluted share in fiscal 2025, compared with $-1.50 a year earlier.
When does enGene's fiscal year end?
enGene's fiscal year ends in October. The latest annual report covers the year ended October 31, 2025 and was filed on December 22, 2025.